Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1116293.RA4eDe7ZibucCnhSN0kpww6lXxMI_BGXLbVetof0KWSGQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1116293.RA4eDe7ZibucCnhSN0kpww6lXxMI_BGXLbVetof0KWSGQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1116293.RA4eDe7ZibucCnhSN0kpww6lXxMI_BGXLbVetof0KWSGQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1116293.RA4eDe7ZibucCnhSN0kpww6lXxMI_BGXLbVetof0KWSGQ130_provenance.
- NP1116293.RA4eDe7ZibucCnhSN0kpww6lXxMI_BGXLbVetof0KWSGQ130_assertion description "[Collectively, these data suggest that ABHD6 inhibitors may serve as therapeutics for obesity, nonalcoholic fatty liver disease, and type II diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116293.RA4eDe7ZibucCnhSN0kpww6lXxMI_BGXLbVetof0KWSGQ130_provenance.
- NP1116293.RA4eDe7ZibucCnhSN0kpww6lXxMI_BGXLbVetof0KWSGQ130_assertion evidence source_evidence_literature NP1116293.RA4eDe7ZibucCnhSN0kpww6lXxMI_BGXLbVetof0KWSGQ130_provenance.
- NP1116293.RA4eDe7ZibucCnhSN0kpww6lXxMI_BGXLbVetof0KWSGQ130_assertion SIO_000772 24095738 NP1116293.RA4eDe7ZibucCnhSN0kpww6lXxMI_BGXLbVetof0KWSGQ130_provenance.
- NP1116293.RA4eDe7ZibucCnhSN0kpww6lXxMI_BGXLbVetof0KWSGQ130_assertion wasDerivedFrom befree-2016 NP1116293.RA4eDe7ZibucCnhSN0kpww6lXxMI_BGXLbVetof0KWSGQ130_provenance.
- NP1116293.RA4eDe7ZibucCnhSN0kpww6lXxMI_BGXLbVetof0KWSGQ130_assertion wasGeneratedBy ECO_0000203 NP1116293.RA4eDe7ZibucCnhSN0kpww6lXxMI_BGXLbVetof0KWSGQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP1116293.RA4eDe7ZibucCnhSN0kpww6lXxMI_BGXLbVetof0KWSGQ130_provenance.